DP
CME icon

Dearborn Partners’s CME Group CME Stock Holding History

Dearborn Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.3M Sell
92,074
-8,366
-8% -$2.31M 1.15% 33
2026
Q1 		$29.7M Buy
100,440
+5,832
+6% +$1.73M 1.61% 19
2025
Q4 		$25.8M Buy
94,608
+82,960
+712% +$22.5M 1.29% 36
2025
Q3 		$3.15M Sell
11,648
-352
-3% -$95.8K 0.15% 80
2025
Q2 		$3.31M Buy
12,000
+9,818
+450% +$2.67M 0.16% 80
2025
Q1 		$579K Buy
2,182
+670
+44% +$165K 0.03% 149
2024
Q4 		$351K Buy
1,512
+77
+5% +$17.7K 0.01% 198
2024
Q3 		$317K Sell
1,435
-2,453
-63% -$508K 0.01% 222
2024
Q2 		$764K Sell
3,888
-5
-0.1% -$1.03K 0.03% 134
2024
Q1 		$838K Buy
3,893
+610
+19% +$128K 0.04% 127
2023
Q4 		$691K Buy
3,283
+421
+15% +$89.8K 0.03% 140
2023
Q3 		$573K Buy
2,862
+1,152
+67% +$229K 0.02% 139
2023
Q2 		$317K Buy
1,710
+11
+0.6% +$2.03K 0.01% 184
2023
Q1 		$325K Buy
1,699
+7
+0.4% +$1.27K 0.01% 179
2022
Q4 		$285K Buy
1,692
+392
+30% +$68.1K 0.01% 198
2022
Q3 		$230K Buy
1,300
+11
+0.9% +$2.17K 0.01% 229
2022
Q2 		$264K Sell
1,289
-207
-14% -$43.9K 0.01% 220
2022
Q1 		$356K Sell
1,496
-200
-12% -$47K 0.01% 191
2021
Q4 		$387K Buy
1,696
+31
+2% +$6.82K 0.01% 193
2021
Q3 		$322K Buy
1,665
+5
+0.3% +$1.01K 0.01% 196
2021
Q2 		$353K Sell
1,660
-70
-4% -$14.8K 0.01% 187
2021
Q1 		$353K Buy
1,730
+537
+45% +$106K 0.02% 180
2020
Q4 		$217K Buy
+1,193
New +$203K 0.01% 241
2014
Q1 		– Sell
-2,554
Closed -$200K – 293
2013
Q4 		$200K Sell
2,554
-1,048
-29% -$82.1K 0.02% 296
2013
Q3 		$266K Buy
3,602
+112
+3% +$8.25K 0.04% 258
2013
Q2 		$265K Buy
+3,490
New +$229K 0.04% 254

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dearborn Partners's CME Position: Q2 2026 in Review

Dearborn Partners reduced its CME Group (CME) stake by 8.3% in Q2 2026, selling an estimated $2.31M and leaving 92,074 shares worth $20.3M. The position accounts for 1.15% of the portfolio, ranked #33.

Dearborn Partners first reported a position in CME in Q2 2013 and has held it in 26 quarters since. The position peaked at $29.7M in Q1 2026. 1,702 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Dearborn Partners held 92,074 shares of CME Group worth $20.3M as of Q2 2026.
  • Dearborn Partners sold 8,366 CME Group shares in Q2 2026, an estimated $2.31M.
  • CME Group made up 1.15% of Dearborn Partners's portfolio in Q2 2026, its #33 holding.
  • Dearborn Partners first reported a position in CME Group in Q2 2013 and has held it in 26 quarters since.
  • Dearborn Partners's CME Group position peaked at $29.7M in Q1 2026.
  • 1,702 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Dearborn Partners's 13F filing for Q2 2026, filed 13 Aug 2026.